GlassScriptPhysician profile
April West Fox
NPI 1134323926
$2,861.96
in general payments reported to CMS, 2019-2025
31 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $423 · 2021: $245 · 2022: $616 · 2023: $875 · 2024: $197 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.79 |
| Travel and Lodging | $296.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $683.23 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $452.49 | 2021-2025 | Interstim |
| Takeda Pharmaceuticals U.S.A., INC. | $399.79 | 2019-2024 | Gattex |
| Davol INC. | $241.69 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip |
| Baxter Healthcare | $163.69 | 2020-2022 | |
| Axonics, INC. | $159.94 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.83 | 2020-2022 | |
| Covidien LP | $79.77 | 2019-2020 | |
| Tela Bio, INC. | $57.77 | 2019-2024 | Ovitex 2s |
| Edwards Lifesciences Corporation | $49.18 | 2020-2024 | |
| Conmed Corporation | $43.44 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $42.99 | 2020-2023 | Exparel |
| Integra Lifesciences Corporation | $38.86 | 2022-2023 | Integra, Surgimend, Omnigraft |
| Biotissue Holdings INC. | $37.33 | 2025 | |
| Hologic Sales and Service, LLC | $36.44 | 2025 | Coolseal Generator |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $33.32 | 2019 | |
| Dilon Technologies, INC. | $28.05 | 2024 | Hemoblast Bellows |
| Abbvie INC. | $27.30 | 2023 | |
| Romark Laboratories, Lc | $22.90 | 2019 | |
| Medspira, LLC | $19.94 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $19.32 | 2020 | |
| Ethicon US, LLC | $19.07 | 2021 | |
| Mallinckrodt Enterprises LLC | $17.19 | 2019 | |
| Baudax Bio INC. | $16.44 | 2020 | |
| Concordia Pharmaceuticals INC. | $16.31 | 2019 | |
| Zyla Life Sciences, INC. | $15.44 | 2020 | |
| Lsi Solutions INC | $13.74 | 2022 | |
| Innovation Technologies INC | $13.46 | 2023 | Irrisept |
| Alfasigma USA, INC. | $11.72 | 2020 | |
| Medtronic USA, INC. | $11.70 | 2019 | |
| Lexington Medical, INC. | $5.62 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.